Neoadjuvant immuno-chemotherapy in resectable non-small cell lung cancer: A retrospective cohort study

被引：0
|
作者：
Verma, Saurav
Vincent, Mark David
Black, Morgan
Nayak, Rahul
Cecchini, Matthew
Malthaner, Richard
Raphael, Jacques
Inculet, Richard
Fortin, Dalilah
Blanchette, Philip
Kuruvilla, Sara
Qiabi, Mehdi
Younus, Jawaid
Breadner, Daniel Adam
机构：
[1] Western Univ, London Reg Canc Program, Schulich Sch Med & Dent, Div Med Oncol,Dept Oncol, London, ON, Canada
[2] Western Univ, London Hlth Sci Ctr, London, ON, Canada
[3] Western Univ, London Hlth Sci Ctr, Schulich Sch Med & Dent, Div Thorac Surg, London, ON, Canada
[4] Western Univ, London Hlth Sci Ctr, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20077
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study
    Weigang Dong
    Yan Yin
    Shengnan Yang
    Bin Liu
    Xi Chen
    Lina Wang
    Yue Su
    Yan Jiang
    Dongsheng Shi
    Daqiang Sun
    Jianwen Qin
    BMC Cancer, 24
  • [42] Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study
    Dong, Weigang
    Yin, Yan
    Yang, Shengnan
    Liu, Bin
    Chen, Xi
    Wang, Lina
    Su, Yue
    Jiang, Yan
    Shi, Dongsheng
    Sun, Daqiang
    Qin, Jianwen
    BMC CANCER, 2024, 24 (01)
  • [43] Real-world comparison of neoadjuvant pembrolizumab plus chemotherapy versus tislelizumab plus chemotherapy in patients with resectable non-small cell lung cancer: a retrospective cohort study of treatment outcomes
    Hu, Yan
    Ren, Siying
    Feng, Juan
    Zeng, Chao
    Yang, Lulu
    Liu, Jinyou
    Wu, Fang
    Liu, Wenliang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02)
  • [44] Efficacy and safety of neoadjuvant tislelizumab combined with chemotherapy in locally advanced non-small cell lung cancer-a retrospective cohort study
    Chen, Hao
    Zhang, Jiarong
    Chen, Chun
    Zheng, Wei
    Zheng, Bin
    JOURNAL OF THORACIC DISEASE, 2024, 16 (01) : 498 - 506
  • [45] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Long Jiang
    Jia Huang
    Shanshan Jiang
    Wenwen Rong
    Yaofeng Shen
    Chongwu Li
    Yu Tian
    Junwei Ning
    Xiaoke Chen
    Yunhai Yang
    Zhengping Ding
    Ziming Li
    Qingquan Luo
    Cancer Immunology, Immunotherapy, 2021, 70 : 2313 - 2321
  • [46] Adjuvant or neoadjuvant therapeutic strategy for resectable non-small cell lung cancer
    Hayashi, Ryuji
    RESPIRATORY INVESTIGATION, 2023, 61 (02) : 133 - 134
  • [47] Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer
    Parekh, Jay
    Parikh, Kaushal
    Reuss, Joshua E.
    Friedlaender, Alex
    Addeo, Alfredo
    CURRENT ONCOLOGY REPORTS, 2023, 25 (08) : 913 - 922
  • [48] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Jiang, L.
    Huang, J.
    Luo, Q.
    ANNALS OF ONCOLOGY, 2020, 31 : S1383 - S1383
  • [49] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Jiang, Long
    Huang, Jia
    Jiang, Shanshan
    Rong, Wenwen
    Shen, Yaofeng
    Li, Chongwu
    Tian, Yu
    Ning, Junwei
    Chen, Xiaoke
    Yang, Yunhai
    Ding, Zhengping
    Li, Ziming
    Luo, Qingquan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2313 - 2321
  • [50] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Jiang, L.
    Luo, Q.
    ANNALS OF ONCOLOGY, 2020, 31 : S1226 - S1226
12345